Event
Date: October 30, 2019
Location: Regenstrief Institute, 1101 W. 10th St., Indianapolis, IN 46202

SAM Talk: Featuring Dr. Claire Snyder, MHS, PhD

SAM Talk: Featuring Dr. Claire Snyder, MHS, PhD

“Personalizing Care Using Patient-Reported Outcomes”

The 2019-2020 Sam Regenstrief Lecture Series

October 30, 2019  11:30AM-12:30PM

Regenstrief Institute, 1101 W. 10th St., Indiananpolis, IN 46202

Claire Snyder, MHS, PhDDr. Claire Snyder researches the quality of cancer care, with a particular focus in quality of life for cancer patients and coordination of care between cancer specialists and primary care providers.

She is investigating the use of patient-reported outcome questionnaires in routine oncology practice. This intervention involves having patients complete questionnaires regarding their functioning and well-being, providing the responses to their clinicians, and evaluating whether the questionnaires help their clinicians identify and address these quality-of-life issues.

In related research, she has developed the PatientViewpoint web tool for collecting these questionnaires and linking the results with the electronic medical record.

Dr. Snyder has also conducted multiple studies using large databases to examine the quality of care for cancer survivors — including preventive and primary care services, comorbid condition care, and cancer follow-up. A particular focus is how involvement of different physician specialties relates to whether survivors receive recommended follow-up. She is also working with a multidisciplinary team to develop survivorship care strategies at Johns Hopkins. Dr. Snyder holds a joint appointment in Health Policy and Management with the Bloomberg School of Public Health.

Related News

Johanne Eliacin and Sophia Wang

Factors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research

Regenstrief researcher leads study of barriers to participation and drivers of engagement The use of Alzheimer’s disease (AD) biomarkers

Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

Study also finds less severe disease during BA.4/BA.5 predominance compared to earlier Omicron variants A multi-state study from the

Dr. Kurt Kroenke at the 2023 Indianapolis Business Journal's Health Care Heroes Awards Breakfast

IBJ Honors Regenstrief research scientist with Heath Care Hero Award 

The Indianapolis Business Journal (IBJ) honored Regenstrief Research Scientist Kurt Kroenke, M.D., MACP, as a Health Care Hero at

LOINC Logo

LOINC 2.74 Release Webinar scheduled for spring 2023

LOINC® from Regenstrief Institute will host an educational webinar for the February 2023 2.74 release of new concepts, scheduled